Doximity, Inc. (DOCS)
| Market Cap | 9.60B |
| Revenue (ttm) | 621.33M |
| Net Income (ttm) | 253.03M |
| Shares Out | 188.27M |
| EPS (ttm) | 1.25 |
| PE Ratio | 40.82 |
| Forward PE | 32.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,289,835 |
| Open | 51.00 |
| Previous Close | 51.07 |
| Day's Range | 50.88 - 51.64 |
| 52-Week Range | 46.04 - 85.21 |
| Beta | 1.36 |
| Analysts | Buy |
| Price Target | 68.05 (+33.51%) |
| Earnings Date | Nov 6, 2025 |
About DOCS
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, ... [Read more]
Financial Performance
In 2024, Doximity's revenue was $570.40 million, an increase of 19.98% compared to the previous year's $475.42 million. Earnings were $223.19 million, an increase of 51.23%.
Financial StatementsAnalyst Summary
According to 20 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $68.05, which is an increase of 33.51% from the latest price.
News
Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript
Doximity, Inc. ( DOCS) Q2 2026 Earnings Call November 6, 2025 5:00 PM EST Company Participants Perry Gold - Head of Investor Relations Jeffrey Tangney - Co-Founder, CEO & Chairperson Anna Bryson - Ch...
Doximity Announces Fiscal 2026 Second Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, ...
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to share...
Doximity to Release Fiscal 2026 Second Quarter Results on November 6, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ...
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and di...
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.
Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Per...
Doximity (DOCS) Q1 Revenue Rises 15%
Doximity (DOCS) Q1 Revenue Rises 15%
Doximity buys Pathway Medical for $63 million to help doctors get AI-powered answers
Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said.
Doximity Acquires Pathway, a Leader in AI Clinical Reference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it has acquired Pathway Medical Inc., a Montreal-based st...
Doximity Announces Fiscal 2026 First Quarter Financial Results
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 first quarter ended June 30, 2025. ...
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the ...
New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2025 Physician Compensation Report. The findings highlight ...
Doximity: Slowing Sales And EBITDA Growth
Doximity shares have dropped nearly 25% from February highs, despite strong Q4 earnings and 17% revenue growth year-over-year. Analyst sentiment is mixed, and insider selling has notably increased in ...
Doximity to Release Fiscal 2026 First Quarter Results on August 7, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter e...
Doximity Crushes The Rule Of 40 - Try Rule Of 58
I have a price target of $85 for Doximity by summer 2026. There is lots to be bullish about. Doximity's fundamentals are strong: zero debt, a large cash cushion, and robust free cash flow generation s...
Doximity: A Unique, Debt-Free Healthcare-Tech Platform, Initiate With 'Buy'
I rate Doximity a 'Buy' with a $62 fair value, citing its dominant network among U.S. healthcare professionals and robust growth trajectory. Doximity's strong pharma marketing business, workflow solut...
Doximity to Present at the William Blair 45th Annual Growth Stock Conference
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the Wil...
Doximity: A Closer Look at Its Investment Potential
Explore the exciting world of Doximity (DOCS -1.43%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potenti...
Doximity: Strong Growth but What's Next?
Here's our initial take on Doximity's (DOCS -10.03%) financial report.
Doximity Stock 7.8% Higher After Key Trading Signal
DOCS reverses steep decline after TradePulse Alert
These Analysts Cut Their Forecasts On Doximity After Q4 Results
Doximity, Inc. DOCS reported better-than-expected earnings for the fourth quarter on Thursday.
Why Doximity Stock Is Plummeting Today
Shares of the leading digital platform for U.S. medical professionals, Doximity (DOCS -10.74%), were down 14% as of noon ET Friday, according to data provided by S&P Global Market Intelligence.
Globant, Doximity, Applied Materials And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.
Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS) Q4 2025 Earnings Conference Call May 15, 2025 5:00 PM ET Company Participants Perry Gold - Head of IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Fo...